This Article Full Text (OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Hammond,, T. M. Articles by Mayrovitz,, H. N. Social Bookmarking                         What's this?

Programmable Intermittent Pneumatic Compression as a Component of Therapy for Breast Cancer Treatment–Related Truncal and Arm Lymphedema

^* To whom correspondence should be addressed. E-mail: mayrovit{at}nova.edu.

	Abstract

Lymphedema is a chronic condition often requiring lifelong treatment to avoid worsening of extremity and trunk swelling with concomitant complications. The physiological basis for truncal treatment, although clinically recognized, until recently, was not well documented. Herein, we expand on earlier work by reporting on clinical outcomes, therapist observations, and subjective impressions of five patients with truncal lymphedema whose in-home self-treatment includes the Flexitouch^® system (FT) pneumatic device. Patients received in-clinic complete decongestive therapy and in-home self-care including FT. Results, determined after 2 months of treatment, showed reductions in trunk and arm swelling, fibrotic tissue softening, pain reduction, and improved range of motion and flexibility. Patients reported that FT was easy and comfortable to use and enhanced in-home compliance. Results suggest that limb and trunk lymphedema can be effectively treated in the home with an advanced programmable pneumatic device with truncal coverage, such as the FT system.

First published on August 17, 2009
Home Health Care Management & Practice 2009, doi:10.1177/1084822309343421


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?